Nuick IV 250 contains Simoctocog Alpha, a recombinant Factor VIII (rFVIII) concentrate indicated for hemophilia A. Developed by Fujimoto Pharmaceutical, this injectable drug (YJ code: 6343457D1029) is available as a 250 IU bottle with dissolving solution.
Nuick IV 250
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).